Exact Mass: 291.1682

Exact Mass Matches: 291.1682

Found 53 metabolites which its exact mass value is equals to given mass value 291.1682, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Eseridine

1,2-Oxazino[6,5-b]indol-6-ol,2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-, 6-(N-methylcarbamate), (4aS,9aS)-

C15H21N3O3 (291.1583)


C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor

   

(3R)-3,5-dihydroxy-3-methylpentanoylcarnitine

3-[(3,5-dihydroxy-3-methylpentanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C13H25NO6 (291.1682)


(3R)-3,5-dihydroxy-3-methylpentanoylcarnitine is an acylcarnitine. More specifically, it is an (3R)-3,5-dihydroxy-3-methylpentanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (3R)-3,5-dihydroxy-3-methylpentanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (3R)-3,5-dihydroxy-3-methylpentanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Perlapine

10-(4-methylpiperazin-1-yl)-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,9,11,13-heptaene

C19H21N3 (291.1735)


   
   

Naphthalen-1-yl(1-pentyl-1H-pyrrol-3-yl)methanone

Naphthalen-1-yl(1-pentyl-1H-pyrrol-3-yl)methanone

C20H21NO (291.1623)


   

1,3-Dibenzylhexahydropyrimidine-5-carbonitrile

1,3-Dibenzylhexahydropyrimidine-5-carbonitrile

C19H21N3 (291.1735)


   

5H-Dibenzo[a,d]cyclohepten-3-ol,5-[3-(dimethylamino)propylidene]-

5H-Dibenzo[a,d]cyclohepten-3-ol,5-[3-(dimethylamino)propylidene]-

C20H21NO (291.1623)


   

TCMDC-134505

TCMDC-134505

C19H21N3 (291.1735)


   
   

3H-1,2,4-Triazol-3-one, 5-ethyl-2,4-dihydro-2-(3-hydroxypropyl)-4-(2-phenoxyethyl)-

3H-1,2,4-Triazol-3-one, 5-ethyl-2,4-dihydro-2-(3-hydroxypropyl)-4-(2-phenoxyethyl)-

C15H21N3O3 (291.1583)


   
   

Ethyl 2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate

Ethyl 2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate

C15H22BNO4 (291.1642)


   

3-ETHYL-1-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-1H-INDAZOL-6-AMINE

3-ETHYL-1-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-1H-INDAZOL-6-AMINE

C15H25N3OSi (291.1767)


   

Cotriptyline

Cotriptyline

C20H21NO (291.1623)


   

tert-butyl 4-(4-formylpyridin-2-yl)piperazine-1-carboxylate

tert-butyl 4-(4-formylpyridin-2-yl)piperazine-1-carboxylate

C15H21N3O3 (291.1583)


   

(2S,6S)-2,6-dibenzyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole

(2S,6S)-2,6-dibenzyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole

C19H21N3 (291.1735)


   

N-[2-HYDROXYETHYL]BENZAMIDE-4-BORONIC ACID, PINACOL ESTER

N-[2-HYDROXYETHYL]BENZAMIDE-4-BORONIC ACID, PINACOL ESTER

C15H22BNO4 (291.1642)


   

N-(2-METHOXY-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ACETAMIDE

N-(2-METHOXY-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ACETAMIDE

C15H22BNO4 (291.1642)


   

4-Anilino-1-benzyl-4-piperidinecarbonitrile

4-Anilino-1-benzyl-4-piperidinecarbonitrile

C19H21N3 (291.1735)


   

amyl 2-acetamido-2-deoxy-beta-d-glucopyranoside

amyl 2-acetamido-2-deoxy-beta-d-glucopyranoside

C13H25NO6 (291.1682)


   

N-methoxy-N-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

N-methoxy-N-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

C15H22BNO4 (291.1642)


   

4-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-yl]morpholine

4-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazin-2-yl]morpholine

C14H22BN3O3 (291.1754)


   

tert-amyl 2-acetamido-2-deoxy-beta-d-glucopyranoside

tert-amyl 2-acetamido-2-deoxy-beta-d-glucopyranoside

C13H25NO6 (291.1682)


   

TRIMETHALLYLISOCYANURATE

TRIMETHALLYLISOCYANURATE

C15H21N3O3 (291.1583)


   

N-(2-hydroxyethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

N-(2-hydroxyethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

C15H22BNO4 (291.1642)


   

3-(N,O-Dimethylhydroxylaminocarbonyl)benzeneboronic acid pinacol ester

3-(N,O-Dimethylhydroxylaminocarbonyl)benzeneboronic acid pinacol ester

C15H22BNO4 (291.1642)


   

tert-butyl 4-(5-formylpyridin-2-yl)piperazine-1-carboxylate

tert-butyl 4-(5-formylpyridin-2-yl)piperazine-1-carboxylate

C15H21N3O3 (291.1583)


   

1,4-BIS(PHENYLMETHYL)-2-PIPERAZINECARBONITRILE

1,4-BIS(PHENYLMETHYL)-2-PIPERAZINECARBONITRILE

C19H21N3 (291.1735)


   

1,3-DIBENZYL-5-CYANOHEXAHYDROPYRIMIDINE

1,3-DIBENZYL-5-CYANOHEXAHYDROPYRIMIDINE

C19H21N3 (291.1735)


   

1H-PYRROLO[2,3-B]PYRIDINE, 4-[4-(PHENYLMETHYL)-1-PIPERIDINYL]-

1H-PYRROLO[2,3-B]PYRIDINE, 4-[4-(PHENYLMETHYL)-1-PIPERIDINYL]-

C19H21N3 (291.1735)


   

2-amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile

2-amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile

C15H21N3O3 (291.1583)


   

trans-4-[5-(4-ethylcyclohexyl)-2-pyrimidyl]benzonitrile

trans-4-[5-(4-ethylcyclohexyl)-2-pyrimidyl]benzonitrile

C19H21N3 (291.1735)


   

2-Pentyl-4,5-diphenyloxazole

2-Pentyl-4,5-diphenyloxazole

C20H21NO (291.1623)


   

2-(4-morpholino)pyrimidine-5-boronic acid pinacol ester

2-(4-morpholino)pyrimidine-5-boronic acid pinacol ester

C14H22BN3O3 (291.1754)


   

ethyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate

ethyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate

C15H22BNO4 (291.1642)


   

POLY(3,3,4,4-BIPHENYLTETRACARBOXYLIC DIANHYDRIDE-CO-1,4-PHENYLENEDIAMINE),AMIC ACID

POLY(3,3,4,4-BIPHENYLTETRACARBOXYLIC DIANHYDRIDE-CO-1,4-PHENYLENEDIAMINE),AMIC ACID

C20H21NO (291.1623)


   

(S)-N-Demethyl Dapoxetine

(S)-N-Demethyl Dapoxetine

C20H21NO (291.1623)


   

N-Desmethyl Dapoxetine

N-Desmethyl Dapoxetine

C20H21NO (291.1623)


   

4-(4-ACETYL-1-PIPERAZINYL)-3-AMINO-BENZOIC ACID ETHYL ESTER

4-(4-ACETYL-1-PIPERAZINYL)-3-AMINO-BENZOIC ACID ETHYL ESTER

C15H21N3O3 (291.1583)


   

Perlapine

Perlapine

C19H21N3 (291.1735)


C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic

   

Butinoline

Butinoline

C20H21NO (291.1623)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

1-[({[4-(Tert-butyl)cyclohexyliden]amino}oxy)carbonyl]-4-fluorobenzene

1-[({[4-(Tert-butyl)cyclohexyliden]amino}oxy)carbonyl]-4-fluorobenzene

C17H22FNO2 (291.1634)


   

(2-Amino-3-phenyl-bicyclo[2.2.1]hept-2-YL)-phenyl-methanone

(2-Amino-3-phenyl-bicyclo[2.2.1]hept-2-YL)-phenyl-methanone

C20H21NO (291.1623)


   

(3R)-3,5-dihydroxy-3-methylpentanoylcarnitine

(3R)-3,5-dihydroxy-3-methylpentanoylcarnitine

C13H25NO6 (291.1682)


   

3-(4-Dimethylaminobenzylidene)anabaseine

3-(4-Dimethylaminobenzylidene)anabaseine

C19H21N3 (291.1735)


   

1-[(E)-1-(4-Tert-butylphenyl)ethylideneamino]-3-propan-2-ylthiourea

1-[(E)-1-(4-Tert-butylphenyl)ethylideneamino]-3-propan-2-ylthiourea

C16H25N3S (291.1769)


   

1-(9-Anthracenylmethyl)-3-piperidinol

1-(9-Anthracenylmethyl)-3-piperidinol

C20H21NO (291.1623)


   

5-methyl-2-[(3S)-piperidin-3-yl]-3-pyridin-4-yl-1H-indole

5-methyl-2-[(3S)-piperidin-3-yl]-3-pyridin-4-yl-1H-indole

C19H21N3 (291.1735)


   
   

3-[(Diethoxyphosphinyl)methyl]-5-pentyl-2-isoxazoline

3-[(Diethoxyphosphinyl)methyl]-5-pentyl-2-isoxazoline

C13H26NO4P (291.1599)


   
   

n,n-dimethyl-2-{1h,2h,3h,9h-pyrrolo[2,1-b]quinazolin-3-yl}aniline

n,n-dimethyl-2-{1h,2h,3h,9h-pyrrolo[2,1-b]quinazolin-3-yl}aniline

C19H21N3 (291.1735)


   

n,n-dimethyl-2-[(3r)-1h,2h,3h,9h-pyrrolo[2,1-b]quinazolin-3-yl]aniline

n,n-dimethyl-2-[(3r)-1h,2h,3h,9h-pyrrolo[2,1-b]quinazolin-3-yl]aniline

C19H21N3 (291.1735)